The double-edge sword of autophagy in cancer: from tumor suppression to pro-tumor activity

R Chavez-Dominguez, M Perez-Medina… - Frontiers in …, 2020 - frontiersin.org
During tumorigenesis, cancer cells are exposed to a wide variety of intrinsic and extrinsic
stresses that challenge homeostasis and growth. Cancer cells display activation of distinct …

MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches

N Amodio, L Raimondi, G Juli, MA Stamato… - Journal of hematology & …, 2018 - Springer
The deeper understanding of non-coding RNAs has recently changed the dogma of
molecular biology assuming protein-coding genes as unique functional biological effectors …

[HTML][HTML] A bioinformatics analysis, pre-clinical and clinical conception of autophagy in pancreatic cancer: complexity and simplicity in crosstalk

M Ashrafizadeh, W Zhang, R Zou, G Sethi… - Pharmacological …, 2023 - Elsevier
Pancreatic cancer (PC) is a serious gastrointestinal tract disease for which the 5-year
survival rate is less than 10%, even in developed countries such as the USA. The genomic …

Noncoding RNA s in disease

E Lekka, J Hall - FEBS letters, 2018 - Wiley Online Library
Noncoding RNA s are emerging as potent and multifunctional regulators in all biological
processes. In parallel, a rapidly growing number of studies has unravelled associations …

Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer

H YiRen, Y YingCong, Y Sunwu, L Keqin, T Xiaochun… - Molecular cancer, 2017 - Springer
Background Chemoresistance has long been recognized as a major obstacle in cancer
therapy. Clarifying the underlying mechanism of chemoresistance would result in novel …

MALAT1 Long Non-Coding RNA: Functional Implications

G Arun, D Aggarwal, DL Spector - Non-coding RNA, 2020 - mdpi.com
The mammalian genome is pervasively transcribed and the functional significance of many
long non-coding RNA (lncRNA) transcripts are gradually being elucidated. Metastasis …

Target c-Myc to treat pancreatic cancer

M Ala - Cancer biology & therapy, 2022 - Taylor & Francis
ABSTRACT C-Myc overexpression is a common finding in pancreatic cancer and predicts
the aggressive behavior of cancer cells. It binds to the promoter of different genes, thereby …

Long noncoding RNAs in cancer and therapeutic potential

A Renganathan, E Felley-Bosco - Long Non Coding RNA Biology, 2017 - Springer
Long noncoding RNAs (lncRNAs) are the major elements of the mammalian transcriptome
that is emerging as a central player controlling diverse cellular mechanisms. Most of the well …

Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma

SK Gautam, SK Batra, M Jain - Molecular cancer, 2023 - Springer
Immunosuppression is a hallmark of pancreatic ductal adenocarcinoma (PDAC),
contributing to early metastasis and poor patient survival. Compared to the localized tumors …

Regulation and function of autophagy in pancreatic cancer

J Li, X Chen, R Kang, H Zeh, DJ Klionsky, D Tang - Autophagy, 2021 - Taylor & Francis
Oncogenic KRAS mutation-driven pancreatic ductal adenocarcinoma is currently the fourth-
leading cause of cancer-related deaths in the United States. Macroautophagy (hereafter …